Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 12PFIZER

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Cosmoprof
Not Confirmed
arrow
Cosmoprof
Not Confirmed

DACOMITINIB

US Patent Number : 8623883

Drug Substance Claim :

Drug Product Claim :

Application Number : 211288

Patent Use Code : U-1403

Delist Requested :

Patent Use Description : FIRST-LINE TREATMENT O...

Patent Expiration Date : 2025-05-05

blank

02

arrow
Cosmoprof
Not Confirmed
arrow
Cosmoprof
Not Confirmed

DACOMITINIB

US Patent Number : 8623883

Drug Substance Claim :

Drug Product Claim :

Application Number : 211288

Patent Use Code : U-1403

Delist Requested :

Patent Use Description : FIRST-LINE TREATMENT O...

Patent Expiration Date : 2025-05-05

blank

03

arrow
Cosmoprof
Not Confirmed
arrow
Cosmoprof
Not Confirmed

DACOMITINIB

US Patent Number : 8623883

Drug Substance Claim :

Drug Product Claim :

Application Number : 211288

Patent Use Code : U-1403

Delist Requested :

Patent Use Description : FIRST-LINE TREATMENT O...

Patent Expiration Date : 2025-05-05

blank

04

arrow
Cosmoprof
Not Confirmed
arrow
Cosmoprof
Not Confirmed

DACOMITINIB

US Patent Number : 10603314

Drug Substance Claim :

Drug Product Claim :

Application Number : 211288

Patent Use Code : U-3337

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-02-02

blank

05

arrow
Cosmoprof
Not Confirmed
arrow
Cosmoprof
Not Confirmed

DACOMITINIB

US Patent Number : 10603314

Drug Substance Claim :

Drug Product Claim :

Application Number : 211288

Patent Use Code : U-3337

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-02-02

blank

06

arrow
Cosmoprof
Not Confirmed
arrow
Cosmoprof
Not Confirmed

DACOMITINIB

US Patent Number : 10603314

Drug Substance Claim :

Drug Product Claim :

Application Number : 211288

Patent Use Code : U-3337

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-02-02

blank

07

arrow
Cosmoprof
Not Confirmed
arrow
Cosmoprof
Not Confirmed

DACOMITINIB

US Patent Number : 10596162

Drug Substance Claim :

Drug Product Claim :

Application Number : 211288

Patent Use Code : U-3338

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-02-02

blank

08

arrow
Cosmoprof
Not Confirmed
arrow
Cosmoprof
Not Confirmed

DACOMITINIB

US Patent Number : 10596162

Drug Substance Claim :

Drug Product Claim :

Application Number : 211288

Patent Use Code : U-3338

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-02-02

blank

09

arrow
Cosmoprof
Not Confirmed
arrow
Cosmoprof
Not Confirmed

DACOMITINIB

US Patent Number : 10596162

Drug Substance Claim :

Drug Product Claim :

Application Number : 211288

Patent Use Code : U-3338

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-02-02

blank

10

arrow
Cosmoprof
Not Confirmed
arrow
Cosmoprof
Not Confirmed

DACOMITINIB

US Patent Number : 7772243

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 211288

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2028-08-26

blank